Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.

@article{Zhang2010MultipleRO,
  title={Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.},
  author={Jian Zhang and Yi Lu and Kenneth J. Pienta},
  journal={Journal of the National Cancer Institute},
  year={2010},
  volume={102 8},
  pages={
          522-8
        }
}
Prostate cancer continues to be the most common nonskin cancer diagnosed and the second leading cause of cancer death in men in the United States. Prostate cancer that has metastasized to bone remains incurable. The interactions between prostate cancer cells and the various cells of the host microenvironment result in enhanced growth of tumor cells and activation of host cells that together culminate in osteoblastic bone metastases. These dynamic tumor-host interactions are mediated by cancer… Expand
Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic.
TLDR
In this chapter, targeting CCL2 in prostate cancer will be used as an example to show translation of laboratory findings from cancer molecular biology to the clinic. Expand
Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis
TLDR
The role of chemokines in metastatic tumor growth within bone is examined and CCL2, CCL3, IL-8/CXCL8, and CXCL12 are consistently involved in promoting osteoclastogenesis and tumor growth. Expand
MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8
Prostate cancer (PCa) is the most common solid tumor in men and the second leading cause of male mortality in North America (1). It is increasingly obvious that chemokines within the tumorExpand
Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models
TLDR
Overall, the data indicate that bindarit is a good candidate for new therapies against prostate and breast tumorigenesis, with an action through impairment of inflammatory cell responses during formation of the tumor–stroma niche microenvironment. Expand
Monocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB Activity
TLDR
CCL2 and NF-κB may be useful therapeutic targets to interfere with inflammation-induced prostate cancer invasion through increased CCL2 expression and increased prostate cancer cell NF-KKB activity. Expand
The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis
TLDR
This review focuses on the functions of chemokine signaling that may affect tumor immunity by recruiting several types of bone marrow-derived cells (BMDC) to the tumor microenvironment of CRC. Expand
CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration.
TLDR
Interaction between CCL2 and CCR2 enhances migration of prostate cancer cells through an increase in αvβ3 integrin production. Expand
Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone
TLDR
The data provide compelling evidence that CCL2 blockade slows PCa growth in bone, both alone and in combination with docetaxel, and support the continued investigations of CCL1 blockade as a treatment for advanced metastatic PCa. Expand
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
TLDR
This review presents an overview of the main cytokines/chemokines, including IL-6, CXCL12, TGFβ, C XCL8, VEGF, RANKL, CCL2, Cx3CL1, IL-1,IL-7,CXCL1 and CXLI, that exert modulatory roles in prostate cancer metastasis and provides extensive description of their aberrant expression patterns in both advanced disease states and metastatic sites. Expand
Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis.
TLDR
It is suggested that bone marrow perturbation by cytotoxic chemotherapy can contribute to bone metastasis via a transient increase in bone marrow myeloid cells and myelogenic cytokines that can be reversed by inhibition of CCL2. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 93 REFERENCES
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption.
TLDR
MCP-1 may promote preosteoclast cell fusion, forming multinucleated tartrate-resistant acid phosphatase-positive osteoclast-like cells, which may provide novel therapeutic targets for treatment of prostate cancer skeletal metastasis. Expand
CCL2 is a potent regulator of prostate cancer cell migration and proliferation.
TLDR
It is shown that human bone marrow endothelial cells secrete significantly higher levels of CCL2 compared to human aortic endothelium cells and human dermal microvascular endothelial Cells, and that an elevated secretion of Ccl2 recruits prostate cancer epithelial cells to the bone microenvironment and regulates their proliferation rate. Expand
A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone.
TLDR
Data suggest that a destructive cascade is driven by tumor cell-derived, PTHrP-mediated induction of CCL2, which facilitates tumor growth via enhanced osteoclastic and endothelial cell activity in bone marrow. Expand
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
TLDR
It is concluded that activation of MCP-1/CCR2 axis promotes PCa growth in bone and suggests that M CP-1 may be a target for PCa progression. Expand
CCR2 expression correlates with prostate cancer progression
TLDR
CCR2 expression correlated with Gleason score and clinical pathologic stages, whereas lower levels of CCR2 were expressed in normal prostate tissues, suggesting that C CR2 may contribute to PCa development. Expand
CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration.
TLDR
The data suggest that CCL2 contributes to prostate cancer growth through the regulation of macrophage infiltration and enhanced angiogenesis within the tumor. Expand
Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential
TLDR
The results suggest for the first time that DARC is a negative regulator of growth in breast cancer, mainly by sequestration of angiogenic chemokines and subsequent inhibition of tumor neovascularity. Expand
CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac
TLDR
A role for HBME‐secreted CCL2 in promoting PCa cell extravasation into the bone microenvironment is suggested and morphologic changes and the ability of the cells to undergo diapedesis through HBME cells are suggested. Expand
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.
TLDR
Observations support a major tumor-promoting role for co-expression of the chemokines in breast malignancy, and agree with the significant association of joint RANTES and MCP-1 expression with advanced stages of breast cancer. Expand
Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo.
TLDR
It is concluded that MCP-1 promotes lung cancer-induced osteoclast activity and thus bone resorptive lesions in vivo, and thus lung cancer patients with bone metastases with localized tumor levels are diagnosed. Expand
...
1
2
3
4
5
...